View in EDS HTML Full Text PDF Full Text

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.

Saved in:
Bibliographic Details
Title: A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.
Authors: Mooradian, Meghan J.1,2, Reuben, Alexandre3, Prieto, Peter A.3, Hazar-Rethinam, Mehlika1,2, Frederick, Dennie T.1, Nadres, Brandon1,2, Piris, Adriano2,4, Juneja, Vikram5,6,7, Cooper, Zachary A.3, Sharpe, Arlene H.2,5,7, Corcoran, Ryan B.1,2, Flaherty, Keith T.1,2, Lawrence, Donald P.1,2, Wargo, Jennifer A.3, Sullivan, Ryan J.1,2,8 rsullivan7@partners.org
Source: OncoImmunology. 2018, Vol. 7 Issue 5, p1-1. 1p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 129234184
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mooradian%2C+Meghan+J%2E%22">Mooradian, Meghan J.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Reuben%2C+Alexandre%22">Reuben, Alexandre</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Prieto%2C+Peter+A%2E%22">Prieto, Peter A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Hazar-Rethinam%2C+Mehlika%22">Hazar-Rethinam, Mehlika</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Frederick%2C+Dennie+T%2E%22">Frederick, Dennie T.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Nadres%2C+Brandon%22">Nadres, Brandon</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Piris%2C+Adriano%22">Piris, Adriano</searchLink><relatesTo>2,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Juneja%2C+Vikram%22">Juneja, Vikram</searchLink><relatesTo>5,6,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Cooper%2C+Zachary+A%2E%22">Cooper, Zachary A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Sharpe%2C+Arlene+H%2E%22">Sharpe, Arlene H.</searchLink><relatesTo>2,5,7</relatesTo><br /><searchLink fieldCode="AR" term="%22Corcoran%2C+Ryan+B%2E%22">Corcoran, Ryan B.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Flaherty%2C+Keith+T%2E%22">Flaherty, Keith T.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Lawrence%2C+Donald+P%2E%22">Lawrence, Donald P.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Wargo%2C+Jennifer+A%2E%22">Wargo, Jennifer A.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Sullivan%2C+Ryan+J%2E%22">Sullivan, Ryan J.</searchLink><relatesTo>1,2,8</relatesTo><i> rsullivan7@partners.org</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22OncoImmunology%22">OncoImmunology</searchLink>. 2018, Vol. 7 Issue 5, p1-1. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=129234184
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2017.1423172
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: 1
    Titles:
      – TitleFull: A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mooradian, Meghan J.
      – PersonEntity:
          Name:
            NameFull: Reuben, Alexandre
      – PersonEntity:
          Name:
            NameFull: Prieto, Peter A.
      – PersonEntity:
          Name:
            NameFull: Hazar-Rethinam, Mehlika
      – PersonEntity:
          Name:
            NameFull: Frederick, Dennie T.
      – PersonEntity:
          Name:
            NameFull: Nadres, Brandon
      – PersonEntity:
          Name:
            NameFull: Piris, Adriano
      – PersonEntity:
          Name:
            NameFull: Juneja, Vikram
      – PersonEntity:
          Name:
            NameFull: Cooper, Zachary A.
      – PersonEntity:
          Name:
            NameFull: Sharpe, Arlene H.
      – PersonEntity:
          Name:
            NameFull: Corcoran, Ryan B.
      – PersonEntity:
          Name:
            NameFull: Flaherty, Keith T.
      – PersonEntity:
          Name:
            NameFull: Lawrence, Donald P.
      – PersonEntity:
          Name:
            NameFull: Wargo, Jennifer A.
      – PersonEntity:
          Name:
            NameFull: Sullivan, Ryan J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2018
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 21624011
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: OncoImmunology
              Type: main
ResultId 1